Detalhe da pesquisa
1.
MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol
; 19(7): 916-929, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29908991
2.
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 17(6): 822-835, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27132212
3.
A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer.
Breast Cancer Res Treat
; 156(2): 301-10, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26975189
4.
A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors.
Breast Cancer Res Treat
; 156(2): 319-30, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26993131
5.
Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology.
Proc Natl Acad Sci U S A
; 110(5): 1941-6, 2013 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-23322736
6.
Expression of tumor-associated antigens in breast cancer subtypes.
Breast
; 49: 202-209, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31869767
7.
A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non-Small Cell Lung Cancer.
Clin Cancer Res
; 26(7): 1725-1735, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31732522
8.
Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells.
J Clin Oncol
; 23(35): 9008-21, 2005 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-16061912
9.
The prevalence of expression of MAGE-A3 and PRAME tumor antigens in East and South East Asian non-small cell lung cancer patients.
Lung Cancer
; 101: 137-144, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27794402
10.
Safety and Immunogenicity of the PRAME Cancer Immunotherapeutic in Patients with Resected Non-Small Cell Lung Cancer: A Phase I Dose Escalation Study.
J Thorac Oncol
; 11(12): 2208-2217, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27544054
11.
Immune responses to a class II helper peptide epitope in patients with stage III/IV resected melanoma.
Clin Cancer Res
; 10(15): 5004-13, 2004 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15297401
12.
Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer.
J Thorac Oncol
; 10(10): 1458-67, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26309191
13.
IFN-gamma responses in peptide-treated melanoma patients measured by an ELISPOT assay using allogeneic dendritic cells.
Anticancer Res
; 24(1): 171-7, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15015594
14.
MAGE-A3-specific anticancer immunotherapy in the clinical practice.
Oncoimmunology
; 2(10): e25995, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24244898
15.
Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy.
J Clin Oncol
; 31(19): 2388-95, 2013 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23715562
16.
Adjuvant MAGE-A3 immunotherapy in resected non-small-cell lung cancer: phase II randomized study results.
J Clin Oncol
; 31(19): 2396-403, 2013 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23715567
17.
Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma.
J Clin Oncol
; 31(19): 2413-20, 2013 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23715572
18.
Gene signature in melanoma associated with clinical activity: a potential clue to unlock cancer immunotherapy.
Cancer J
; 16(4): 399-403, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20693853
19.
Dermatomyositis occurring during treatment of a patient with metastatic melanoma.
Melanoma Res
; 14(5): 435-6, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15457104
20.
Cancer immunotherapy targeting tumour-specific antigens: towards a new therapy for minimal residual disease.
Expert Opin Biol Ther
; 8(7): 951-68, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18549325